Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals Shareholders Equity (Quarterly) : 104.83M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 104.83M |
| March 31, 2026 | 98.88M |
| December 31, 2025 | 80.31M |
| September 30, 2025 | 61.58M |
| June 30, 2025 | 47.68M |
| March 31, 2025 | 53.52M |
| December 31, 2024 | 36.45M |
| September 30, 2024 | 47.27M |
| June 30, 2024 | 58.25M |
| March 31, 2024 | 57.58M |
| December 31, 2023 | 46.41M |
| September 30, 2023 | 45.09M |
| June 30, 2023 | 30.12M |
| March 31, 2023 | 28.96M |
| December 31, 2022 | 30.17M |
| September 30, 2022 | 27.19M |
| June 30, 2022 | 25.53M |
| March 31, 2022 | 25.22M |
| December 31, 2021 | 22.79M |
| September 30, 2021 | 20.50M |
| June 30, 2021 | 18.70M |
| March 31, 2021 | 16.15M |
| December 31, 2020 | 16.63M |
| September 30, 2020 | 14.62M |
| June 30, 2020 | 11.79M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.66M |
| December 31, 2019 | 9.080M |
| September 30, 2019 | 10.85M |
| June 30, 2019 | 12.04M |
| March 31, 2019 | 11.40M |
| December 31, 2018 | 13.64M |
| September 30, 2018 | 15.67M |
| June 30, 2018 | 16.99M |
| March 31, 2018 | 18.48M |
| December 31, 2017 | 19.89M |
| September 30, 2017 | 20.09M |
| June 30, 2017 | 17.68M |
| March 31, 2017 | 25.66M |
| December 31, 2016 | 26.05M |
| September 30, 2016 | 22.48M |
| June 30, 2016 | 15.54M |
| March 31, 2016 | 11.16M |
| December 31, 2015 | -2.069M |
| September 30, 2015 | 12.49M |
| June 30, 2015 | 8.332M |
| March 31, 2015 | -34.73M |
| December 31, 2014 | -30.54M |
| September 30, 2014 | -55.36M |
| June 30, 2014 | -84.45M |
| March 31, 2014 | -81.20M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 903.12M |
| Daré Bioscience, Inc. | -0.5601M |
| Eton Pharmaceuticals, Inc. | 46.58M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 139.67M |
| Total Liabilities (Quarterly) | 34.84M |
| Debt to Equity Ratio | 0.0532 |
| Current Ratio | 3.761 |
| Net Debt Paydown Yield | 0.27% |